{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:26Z","timestamp":1761630626142},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.eimc.2012.06.014","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T19:00:35Z","timestamp":1345143635000},"page":"76-81","source":"Crossref","is-referenced-by-count":10,"title":["Use of Quantiferon-TB-Gold in Tube\u00ae test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice"],"prefix":"10.1016","volume":"31","author":[{"given":"Mercedes","family":"Garc\u00eda-Gasalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Fern\u00e1ndez-Baca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Juan-Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Payeras-Cifre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cifuentes-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Taberner-Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Riera-Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculada","family":"Ros-Villamaj\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Navarro-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Morey Torrandell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gallegos-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mir-Villadrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2012.06.014_bib0005","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor -neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2012.06.014_bib0010","unstructured":"www.fda.gov\/drugs\/DrugSafety\/postmarket. Drug safety Information for Health Care Professionals\/ucm180694.htm."},{"key":"10.1016\/j.eimc.2012.06.014_bib0015","unstructured":"Medicines Agency European Public Assessment Reports... Remicade. www.emea.europa.eu [accessed 08.05.12]."},{"key":"10.1016\/j.eimc.2012.06.014_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use. Other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.eimc.2012.06.014_bib0025","first-page":"1436","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis","volume":"30","author":"Carmona","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.eimc.2012.06.014_bib0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumor necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimc.2012.06.014_bib0035","unstructured":"WHO Online Tuberculosis Database. http:\/\/apps.who.int\/globalatlas [accessed 08.05.12]."},{"key":"10.1016\/j.eimc.2012.06.014_bib0040","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.286.14.1740","article-title":"Comparison of a whole-blood interferon-gamma assay with tuberculin testing for detecting latent Mycobacterium tuberculosis infection","volume":"286","author":"Mazureck","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2012.06.014_bib0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","article-title":"Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells","volume":"163","author":"Lalvani","year":"2001","journal-title":"Am Respir Crit Care Med"},{"key":"10.1016\/j.eimc.2012.06.014_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2012.06.014_bib0055","first-page":"620","article-title":"Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy","volume":"137","author":"Beglinger","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.eimc.2012.06.014_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0029-1214673","article-title":"Recommendations for tuberculosis screening before initiation of TNF-alpha inhibitor treatment in Rheumatic Diseases","volume":"63","author":"Diel","year":"2009","journal-title":"Pneumologie"},{"key":"10.1016\/j.eimc.2012.06.014_bib0065","doi-asserted-by":"crossref","first-page":"297.e1","DOI":"10.1016\/j.eimc.2010.02.006","article-title":"Documento de consenso sobre diagn\u00f3stico, tratamiento y prevenci\u00f3n de la tuberculosis","volume":"28","author":"Gonz\u00e1lez Mart\u00edn","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2012.06.014_bib0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13126836","article-title":"Diagnosis and treatment of tuberculosis","volume":"44","author":"Ruiz-Manzano","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.eimc.2012.06.014_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1157\/13083915","article-title":"Recomendaciones sobre tuberculosis y tratamiento de la enfermedad inflamatoria intestinal con infliximab. Actualizaci\u00f3n 2006","volume":"29","author":"L\u00f3pez-San Rom\u00e1n","year":"2006","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.eimc.2012.06.014_bib0080","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.eimc.2012.06.014_bib0085","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ibd.20496","article-title":"Tuberculosis chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy","volume":"14","author":"Zabana","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0090","doi-asserted-by":"crossref","first-page":"221S","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eimc.2012.06.014_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.eimc.2012.06.014_bib0100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimc.2012.06.014_bib0105","unstructured":"INE (National Statistics Institute) base historia. Fondo documental. http:\/\/www.ine.es\/inebaseweb\/treeNavigation.do?tn=30270&tns=30313."},{"key":"10.1016\/j.eimc.2012.06.014_bib0110","doi-asserted-by":"crossref","first-page":"e2665","DOI":"10.1371\/journal.pone.0002665","article-title":"Interferon-gamma release assay for the diagnosis of latent Tb infection-analysis of discordant results, when compared to the tuberculin skin test","volume":"3","author":"Nienhaus","year":"2008","journal-title":"PLos One"},{"key":"10.1016\/j.eimc.2012.06.014_bib0115","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5588\/ijtld.10.0650","article-title":"Predictors of Discordant tuberculin skin test and QuantiFERON\u00ae-TB Gold in Tube results in various high-risk groups","volume":"15","author":"Weinfurter","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0120","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"Mori","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.7326\/0003-4819-120-3-199402010-00003","article-title":"The booster effect in two-step tuberculin testing among young adults in Montreal","volume":"120","author":"Menzies","year":"1994","journal-title":"Ann Intern Med"},{"issue":"Suppl. 3","key":"10.1016\/j.eimc.2012.06.014_bib0130","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/314075","article-title":"What does tuberculin reactivity after bacilli Calmette-Gu\u00e9rin vaccination tell us?","volume":"31","author":"Menzies","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0135","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/archinte.161.14.1760","article-title":"The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees","volume":"161","author":"Moreno","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2012.06.014_bib0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09031936.00196608","article-title":"Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis","volume":"35","author":"Latorre","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimc.2012.06.014_bib0145","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivative in patients with rheumathoid arthritis: study in a population with a high prevalence of tuberculosis","volume":"64","author":"Ponce de Le\u00f3n","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0150","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.eimc.2012.06.014_bib0155","first-page":"1177","article-title":"Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumor necrosis alfa blockers","volume":"11","author":"Cobanoglu","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0160","first-page":"776","article-title":"Comparison of an Interferon-\u03b3 Assay with Tuberculin-Skin Testing for Detection of Tuberculosis (TB) Infection in Patients with Rheumatoid Arthritis in a TB-Endemic Population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.eimc.2012.06.014_bib0205","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10067-012-1938-z","article-title":"Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment","volume":"31","author":"M\u00ednguez","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.eimc.2012.06.014_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen specific interferon \u03b3 assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/kem351","article-title":"Evaluation of latent tuberculosis infection in patients with inflammatory arthropahies before treatment with TNF\u03b1 blocking drugs using a novel flow-cytometric interferon-\u03b3 release assay","volume":"47","author":"Dinser","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.eimc.2012.06.014_bib0180","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diagmicrobio.2010.12.020","article-title":"Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-\u03b3 release assay in patients considered for anti-tumor necrosis factor-\u03b1 therapy","volume":"71","author":"Casas","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacteriunm tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.eimc.2012.06.014_bib0195","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eimc.2012.06.014_bib0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonist: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Burst","year":"2006","journal-title":"Semin Arthritis and Rheum"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X12002315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X12002315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T22:38:22Z","timestamp":1562107102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X12002315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0213005X12002315"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2012.06.014","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}